| Malabsorption Blood Test:Toward a Novel Approach to Quantify Steatorrhea (NCT00572975) | Children's Hospital of Philadelphia | 2006-08-01 |
| 18FDG- PET/CT Contribution to the Assessment of Lesion Severity in Cystic Fibrosis (CF) (NCT00363402) | Hadassah Medical Organization | 2006-08-01 |
| Capsule Endoscopy in Cystic Fibrosis (NCT00333957) | Hadassah Medical Organization | 2006-07-01 |
| Study of Denufosol Inhalation Solution in Patients With Mild Cystic Fibrosis Lung Disease (NCT00357279) | Merck Sharp & Dohme LLC | 2006-07-01 |
| Magnetic Resonance Imaging (MRI) for Early Diagnosis of Cystic Fibrosis (CF) (NCT00760071) | German Cancer Research Center | 2006-07-01 |
| Pharmacokinetic Study of Lansoprazole in Cystic Fibrosis (NCT00458614) | Arkansas Children's Hospital Research Institute | 2006-06-01 |
| Can Quantitative Ultrasound be Used for the Evaluation of Bone Health in Adolescents and Adults With Cystic Fibrosis (NCT00221572) | University Hospital, Ghent | 2006-06-01 |
| Study to Evaluate the Safety and Efficacy of EUR-1008 (APT-1008) Pancreatic Enzyme Product in Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency (NCT00297167) | Forest Laboratories | 2006-05-01 |
| Tobramycin Inhalation Solution Administered by eFlow Rapid Nebulizer: Scintigraphy Study (NCT00399945) | Novartis | 2006-05-01 |
| Blood Collection From Individuals With Lung Disease for Genetic Studies (Qatar) (NCT00504361) | Weill Medical College of Cornell University | 2006-05-01 |
| Study of Pancreatic Enzyme Product in Pediatric Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency (NCT00981214) | Forest Laboratories | 2006-05-01 |
| Rare Genetic Disorders of the Breathing Airways (NCT00323167) | University of North Carolina, Chapel Hill | 2006-05-01 |
| Safety and Efficacy of Pioglitazone as an Anti-inflammatory for the Treatment of Cystic Fibrosis (CF) Lung Disease (NCT00322868) | University Hospitals Cleveland Medical Center | 2006-04-01 |
| Tobramycin Administered by eFlow Rapid Nebulizer: Pharmacokinetic Study (NCT00420836) | Novartis | 2006-04-01 |
| Hydroxychloroquine in Cystic Fibrosis (NCT00311883) | Vanderbilt University | 2006-03-01 |
| Self Drainage in Pediatric Cystic Fibrosis Patients (NCT01509235) | Hospices Civils de Lyon | 2006-03-01 |
| Inhaled Sodium Pyruvate for the Treatment of Cystic Fibrosis. (NCT00308243) | Emphycorp | 2006-03-01 |
| Antimicrobial Resistance in Cystic Fibrosis (CF) (NCT00360503) | Seattle Children's Hospital | 2006-03-01 |
| Tolerability of Hypertonic Saline in Infants With Cystic Fibrosis (NCT00753987) | The Hospital for Sick Children | 2006-03-01 |
| Metabolic Abnormalities in Hispanic Children With Cystic Fibrosis (NCT00287443) | University of Texas Southwestern Medical Center | 2006-02-02 |
| A Phase I Study of Inhaled Sodium Pyruvate for the Treatment of Cystic Fibrosis. (NCT00332215) | University of Minnesota | 2006-02-01 |
| Safety of Tobramycin Inhalation Powder (TIP) vs Tobramycin Solution for Inhalation in Patients With Cystic Fibrosis (NCT00388505) | Novartis Pharmaceuticals | 2006-02-01 |
| Comparison of Airway Clearance Efficacy of Two High Frequency Chest Wall Oscillation (HFCWO) Devices in Cystic Fibrosis (NCT00308958) | University of Minnesota | 2006-02-01 |
| One Year Glargine Treatment in CFRD Children and Adolescents (NCT00483769) | Federico II University | 2006-02-01 |
| Azithromycin in Patients With CF, Infected With Burkholderia Cepacia Complex (NCT00298922) | Unity Health Toronto | 2006-02-01 |
| Growth Hormone Use in Adolescents and Adults With Cystic Fibrosis (NCT00287430) | University of Texas Southwestern Medical Center | 2006-01-01 |
| Safety Study of Inhaled 552-02 in Cystic Fibrosis Patients (NCT00274313) | Parion Sciences | 2006-01-01 |
| Behavioral & Nutritional Treatment to Help CF Preschoolers Grow (NCT00241969) | Children's Hospital Medical Center, Cincinnati | 2006-01-01 |
| A Study of Home Monitoring in Adults With Cystic Fibrosis (HOMECF) (NCT02994706) | Heart of England NHS Trust | 2006-01-01 |
| Pre-flight Evaluation of Adult Patients With Cystic Fibrosis (NCT01569880) | Oslo University Hospital | 2006-01-01 |
| FLAME: Airway Inflammation Monitoring in Asthma and Cystic Fibrosis (NCT00404859) | Maastricht University Medical Center | 2006-01-01 |
| Nasal Inhalation of Dornase Alfa (Pulmozyme) in Patients With Cystic Fibrosis and Chronic Rhinosinusitis (NCT00265434) | University of Jena | 2005-12-01 |
| Cystic Fibrosis and Totally Implantable Vascular Access Devices (NCT00244270) | Assistance Publique - Hôpitaux de Paris | 2005-12-01 |
| Prevalence of Chronic Rhinosinusitis in Cystic Fibrosis (NCT00266474) | University of Jena | 2005-12-01 |
| Safety and Efficacy of Ataluren (PTC124) for Cystic Fibrosis (NCT00237380) | PTC Therapeutics | 2005-11-30 |
| Comparison of Inhaled Mannitol and rhDNase in Children With Cystic Fibrosis (NCT00117208) | Syntara | 2005-11-01 |
| Assessing Mucociliary Clearance and Airway Liquid Volume in the CF Airway (NCT00248755) | University of Pittsburgh | 2005-11-01 |
| Mannitol Dose Response Study in Cystic Fibrosis (NCT00251056) | Syntara | 2005-10-01 |
| Blood Collection From Individuals With Lung Disease for Genetic Studies (NCT00362739) | Weill Medical College of Cornell University | 2005-09-01 |
| Tobramycin Inhalation Powder (TIP) in Cystic Fibrosis Subjects (NCT00125346) | Novartis | 2005-09-01 |
| PTC124 for Cystic Fibrosis (NCT00234663) | PTC Therapeutics | 2005-09-01 |
| Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis (CF) Patients With Pseudomonas Aeruginosa (PA) (NCT00128492) | Gilead Sciences | 2005-08-01 |
| Study on the Efficacy of Slow Release Insulin in Cystic Fibrosis Patients With Glucide Intolerance and Clinical Decay (NCT00687466) | Fondazione per la ricerca sulla Fibrosi Cistica | 2005-08-01 |
| A Study in Pediatric Patients With Cystic Fibrosis Lung Disease (NCT00130182) | Merck Sharp & Dohme LLC | 2005-08-01 |
| Using Health-related Quality of Life (HRQL) in Routine Clinical Care (NCT00457301) | University of Alberta | 2005-07-01 |
| An Effectiveness, Safety, and Palatability Study of Pancrelipase Microtablets in Infants and Toddlers With Cystic Fibrosis and Fat Malabsorption (NCT00217204) | McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. | 2005-07-01 |
| Whole Body Vibration - a New Therapeutic Approach to Improve Muscle Function in CF (NCT00388466) | University of Cologne | 2005-06-01 |
| Effect of Non-Invasive Ventilation in Cystic Fibrosis Patient With Chronic Respiratory Failure. (NCT00208078) | Cochin Hospital | 2005-05-01 |
| International Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa (NCT00112359) | Gilead Sciences | 2005-05-01 |
| Safety Study of Orally Administered Curcuminoids in Adult Subjects With Cystic Fibrosis (NCT00219882) | Ramsey, Bonnie, MD | 2005-04-01 |
| Mechanisms of Immune Tolerance and Inflammation in Patients With Cystic Fibrosis With ABPA (NCT00585364) | University of Pittsburgh | 2005-03-01 |
| Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa (NCT00104520) | Gilead Sciences | 2005-02-01 |
| Effectiveness of Pulmozyme in Infants With Cystic Fibrosis (NCT00179998) | Nationwide Children's Hospital | 2005-01-01 |
| EZ-2053 in the Prophylaxis of Acute Pulmonary Allograft Rejection (NCT00105183) | Neovii Biotech | 2005-01-01 |
| Study of Denufosol Tetrasodium in Patients With Cystic Fibrosis Lung Disease (NCT00103714) | Merck Sharp & Dohme LLC | 2005-01-01 |
| The EPIC Observational Study (NCT00676169) | CF Therapeutics Development Network Coordinating Center | 2004-10-01 |
| Serum Zn Status of Patients With Cystic Fibrosis at Diagnosis and One Year Later, Compared to a Healthy Control Group (NCT00221559) | University Hospital, Ghent | 2004-09-01 |
| Multi Breath Nitrogen Washout (MBNW) as a Measure of Small Airway Function in Patients With Respiratory Disease (NCT00163696) | Bayside Health | 2004-09-01 |
| Assessment of Heart and Heart-Lung Transplant Patient Outcomes Following Pulmonary Rehabilitation (NCT00129350) | Royal Brompton & Harefield NHS Foundation Trust | 2004-09-01 |
| Comparison of Two Treatment Regimens to Reduce PA Infection in Children With Cystic Fibrosis (NCT00097773) | Seattle Children's Hospital | 2004-09-01 |
| Assessment of Inflammatory Mediators (AIM) (NCT00219895) | Ramsey, Bonnie, MD | 2004-08-01 |
| Effect of Simvastatin on CF Airway Inflammation (NCT00255242) | Akron Children's Hospital | 2004-07-01 |
| Comparison of Antibiotics for Pseudomonas in Early CF (NCT00823238) | University of North Carolina, Chapel Hill | 2004-07-01 |
| Safety and Tolerability of Inhaled Nitric Oxide in Patients With Cystic Fibrosis (NCT00570349) | Mallinckrodt | 2004-07-01 |
| Non-Invasive Biomarkers in Cystic Fibrosis (NCT00413140) | Maastricht University Medical Center | 2004-06-01 |
| Alpha1 Antitrypsin Aerosol Therapy in Cystic Fibrosis (NCT02010411) | Université de Sherbrooke | 2004-06-01 |
| Oral TheraCLEC™ - Total in Cystic Fibrosis Subjects With Exocrine Pancreatic Insufficiency (NCT00095732) | Anthera Pharmaceuticals | 2004-06-01 |
| Single Dose Escalation Study of TR02 (Sustained Lipid Inhalation Technology [SLIT™] Amikacin) in Participants With Cystic Fibrosis (CF) Having Chronic Infections of Pseudomonas Aeruginosa (NCT06238856) | Insmed Incorporated | 2004-05-12 |
| Zinc Homeostasis and Kinetics in Children With Cystic Fibrosis (CF) (NCT00104494) | Cystic Fibrosis Foundation | 2004-05-01 |
| Effects of 5-Methyltetrahydrofolate and Vitamin B12 Supplemetation on Red Cell Membrane in Children With Cystic Fibrosis (NCT00730509) | Universita di Verona | 2004-04-01 |
| Standard vs. Biofilm Susceptibility Testing in Cystic Fibrosis (CF) (NCT00153634) | Seattle Children's Hospital | 2004-03-01 |
| An Interactive Program to Improve Care for Children With CF (NCT00185549) | Stanford University | 2004-03-01 |
| Genetic Modifiers of Cystic Fibrosis (CF) Liver Disease (NCT00804583) | University of North Carolina, Chapel Hill | 2004-03-01 |
| A Phase 2 Study to Determine the Safety and Efficacy of Inhaled Dry Powder Mannitol in Cystic Fibrosis (NCT00455130) | Syntara | 2004-03-01 |
| Treatment of Metabolic Alkalosis in Acute Exacerbations of Cystic Fibrosis (NCT00163852) | Bayside Health | 2004-02-01 |
| Mucin in Sputum of CF During Pulmonary Exacerbation (NCT00202072) | Philipps University Marburg | 2004-01-01 |
| Study of Alendronate to Prevent and Treat Osteoporosis in Cystic Fibrosis Patients (NCT00157690) | McMaster University | 2003-12-01 |
| Deposition of Inhaled Prolastin in Cystic Fibrosis Patients (NCT00486837) | Grifols Therapeutics LLC | 2003-12-01 |
| Efficacy and Safety of 28 or 56 Day Treatment for Pseudomonas Aeruginosa in Children With Cystic Fibrosis (NCT00391976) | Novartis | 2003-11-01 |
| Anti-pseudomonas IgY to Prevent Infections in Cystic Fibrosis (NCT00633191) | Immunsystem AB | 2003-11-01 |
| A Study to Evaluate Nutropin AQ for the Treatment of Growth Restriction in Children With Cystic Fibrosis (NCT00079742) | Genentech, Inc. | 2003-09-01 |
| Nasal Potential Difference (NPD) for the Diagnosis of Cystic Fibrosis (NCT00589745) | Children's Hospital of Philadelphia | 2003-09-01 |
| Safety and Efficacy of Recombinant Adeno-Associated Virus Containing the CFTR Gene in the Treatment of Cystic Fibrosis (NCT00073463) | Targeted Genetics Corporation | 2003-06-01 |
| Aztreonam for Inhalation (AI) in Patients With Cystic Fibrosis & P. Aeruginosa Infection (NCT01055847) | Gilead Sciences | 2003-06-01 |
| Efficacy and Safety of 24 Weeks of Oral Treatment With BIIL 284 BS in Adult and Pediatric Patients (NCT00060801) | Boehringer Ingelheim | 2003-05-01 |
| Study of INS37217 Inhalation Solution in Mild to Moderate Cystic Fibrosis Lung Disease (NCT00056147) | Merck Sharp & Dohme LLC | 2003-04-01 |
| Investigating Mucinase Activity in Airway Disease (NCT00596232) | University of California, San Francisco | 2003-04-01 |
| Increased Gluconeogenesis is One Cause of Cystic Fibrosis Related Diabetes (CFRD) (NCT00082238) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2003-03-01 |
| Use of Formula Fortified With DHA in Infants With Cystic Fibrosis (NCT00530244) | University of Massachusetts, Worcester | 2003-03-01 |
| Non-invasive Ventilation and Oxygen Therapy in Cystic Fibrosis Patients With Nocturnal Oxygen Desaturation (NCT00157183) | Bayside Health | 2003-03-01 |
| Phenylbutyrate/Genistein Duotherapy in Delta F508-Heterozygotes (for Cystic Fibrosis) (NCT00590538) | Children's Hospital of Philadelphia | 2003-02-01 |
| Interest of Gentamicin-induced Readthrough in Cystic Fibrosis Patients (NCT00376428) | Assistance Publique - Hôpitaux de Paris | 2003-01-01 |
| Treatment of Low Bone Density in Cystic Fibrosis. (NCT01812551) | Istituto Auxologico Italiano | 2002-10-01 |
| Connexin Genotypes in Cystic Fibrosis (NCT04242420) | University Childrens' Hospital (Zentrum für Kinderheilkunde des Universitätsklinikum Bonn) | 2002-04-01 |
| Safety, Tolerability and Pharmacokinetics of BIIL 284 BS in Adult and Pediatric Cystic Fibrosis (CF) Patients (NCT02269189) | Boehringer Ingelheim | 2002-04-01 |
| Study of Interferon Gamma-1b by Injection for the Treatment of Patients With Cystic Fibrosis (NCT00043342) | InterMune | 2002-04-01 |
| Inhaled Bicarbonate Therapy in Cystic Fibrosis (NCT00177645) | University of Pittsburgh | 2002-03-01 |
| Prevalence and Treatment of Urinary Incontinence in Women With Cystic Fibrosis and Chronic Obstructive Pulmonary Disease (NCT00164138) | Bayside Health | 2001-12-01 |
| Safety, Tolerability and Pharmacokinetics of Increasing Doses of BIIL 284 BS in Adult and Pediatric Cystic Fibrosis (CF) Patients (NCT02265679) | Boehringer Ingelheim | 2001-10-01 |
| Continuous Versus Short Infusions of Ceftazidime in Cystic Fibrosis (NCT00333385) | Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche | 2001-10-01 |